chr16-4434417-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_005147.6(DNAJA3):c.245C>T(p.Ser82Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005147.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJA3 | NM_005147.6 | c.245C>T | p.Ser82Phe | missense_variant | 2/12 | ENST00000262375.11 | NP_005138.3 | |
DNAJA3 | NM_001135110.3 | c.245C>T | p.Ser82Phe | missense_variant | 2/11 | NP_001128582.1 | ||
DNAJA3 | XM_047434875.1 | c.245C>T | p.Ser82Phe | missense_variant | 2/11 | XP_047290831.1 | ||
DNAJA3 | NM_001286516.2 | c.102-7089C>T | intron_variant | NP_001273445.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJA3 | ENST00000262375.11 | c.245C>T | p.Ser82Phe | missense_variant | 2/12 | 1 | NM_005147.6 | ENSP00000262375.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250824Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135582
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461316Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 726970
GnomAD4 genome AF: 0.000112 AC: 17AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74318
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at